Brief: Hikma And Richter Announce FDA Submission Acceptance For Denosumab Biosimilar Products
12/12/2024 07:27
Dec 12 (Reuters) - Hikma Pharmaceuticals PLC HIK.L :
* HIKMA AND RICHTER ANNOUNCE FDA SUBMISSION ACCEPTANCE FOR
DENOSUMAB BIOSIMILAR PRODUCTS
Source text: ID:
Further company coverage: HIK.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection